Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-15 Sale |
2021-09-17 5:11 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $229.44 | $1,147,193 | 115,706 (Direct) |
View |
2021-09-15 Sale |
2021-09-17 5:08 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,183 | $229.34 | $271,304 | 16,057 (Direct) |
View |
2021-09-13 Sale |
2021-09-15 5:03 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
14,998 | $235.95 | $3,538,794 | 258,221 (Direct) |
View |
2021-09-01 Sale |
2021-09-03 5:10 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $247.97 | $1,239,867 | 120,706 (Direct) |
View |
2021-08-31 Sale |
2021-09-01 5:23 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,386 | $239.87 | $332,463 | 4,061 (Direct) |
View |
2021-08-26 Sale |
2021-08-30 6:16 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
4,239 | $233.86 | $991,324 | 91,959 (Direct) |
View |
2021-08-16 Sale |
2021-08-18 5:26 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,866 | $233.52 | $435,750 | 17,240 (Direct) |
View |
2021-07-26 Sale |
2021-07-28 5:00 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,896 | $197.74 | $572,648 | 63,519 (Direct) |
View |
2021-07-20 Sale |
2021-07-22 5:20 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,409 | $215.43 | $518,982 | 2,811 (Direct) |
View |
2021-07-15 Sale |
2021-07-19 7:52 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
5,815 | $179.44 | $1,043,438 | 113,698 (Direct) |
View |
2021-07-01 Sale |
2021-07-06 5:03 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
105,179 | $214.38 | $22,548,579 | 73,054 (Direct) |
View |
2021-06-30 Sale |
2021-07-02 5:01 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,896 | $212.65 | $615,848 | 66,415 (Direct) |
View |
2021-06-15 Sale |
2021-06-17 6:17 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,281 | $188.97 | $1,564,826 | 121,216 (Direct) |
View |
2021-06-01 Sale |
2021-06-03 5:34 pm |
NOVAVAX INC | NVAX | EVANS GARY C Director |
625 | $146.5 | $91,563 | 16,099 (Indirect Direct) |
View |
2021-05-28 Sale |
2021-06-02 4:59 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $149.14 | $431,748 | 68,880 (Direct) |
View |
2021-05-19 Purchase |
2021-05-21 5:06 pm |
NOVAVAX INC | NVAX | King Rachel K. Director |
700 | $139.64 | $97,748 | 5,000 (Indirect Direct) |
View |
2021-05-17 Sale |
2021-05-19 5:26 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,302 | $136.48 | $1,133,066 | 131,751 (Direct) |
View |
2021-05-05 Sale |
2021-05-07 5:10 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
3,226 | $184.88 | $596,434 | 85,585 (Direct) |
View |
2021-04-30 Sale |
2021-05-04 6:03 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $239.83 | $694,317 | 71,775 (Direct) |
View |
2021-04-15 Sale |
2021-04-19 9:24 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,271 | $206.04 | $1,704,136 | 142,282 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-09-15 Exercise |
2021-09-17 5:11 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 115,706 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 5:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 115,706 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 5:08 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,183 | $0 | 16,057 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
662 | $46 | 16,057 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
521 | $27.6 | 16,057 (Direct) |
View |
2021-09-13 Exercise |
2021-09-15 5:03 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
14,998 | $0 | 258,221 (Direct) |
View |
2021-09-13 Exercise |
2021-09-15 5:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
14,998 | $19.08 | 258,221 (Direct) |
View |
2021-09-01 Exercise |
2021-09-03 5:10 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 120,706 (Direct) |
View |
2021-09-01 Exercise |
2021-09-03 5:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 120,706 (Direct) |
View |
2021-08-26 Exercise |
2021-08-30 6:16 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
6,921 | $0 | 91,959 (Direct) |
View |
2021-08-26 Exercise |
2021-08-30 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
6,921 | $5.95 | 91,959 (Direct) |
View |
2021-08-26 Tax Withholding |
2021-08-30 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,296 | $230.34 | 91,959 (Direct) |
View |
2021-08-19 Option Award |
2021-08-20 5:32 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
1,965 | $0 | 1,965 (Direct) |
View |
2021-06-25 Exercise(A) |
2021-08-20 5:30 pm |
N/A N/A |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
3,450 | $0 | 12,851 (Direct) |
View |
2021-06-25 Exercise(A) |
2021-08-20 5:29 pm |
N/A N/A |
NOVAVAX INC | NVAX | King Rachel K. Director |
3,450 | $0 | 9,700 (Direct) |
View |
2021-08-16 Exercise |
2021-08-18 5:26 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,866 | $0 | 17,240 (Direct) |
View |
2021-08-16 Exercise |
2021-08-18 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,322 | $46 | 17,240 (Direct) |
View |
2021-08-16 Exercise |
2021-08-18 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
544 | $27.6 | 17,240 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 5:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Kelly James Patrick EVP, CFO and Treasurer |
21,300 | $0 | 21,300 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 5:00 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,896 | $0 | 63,519 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 5:00 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
417 | $46 | 63,519 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 5:00 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,062 | $5.95 | 63,519 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 5:00 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
417 | $27.6 | 63,519 (Direct) |
View |
2021-07-15 Tax Withholding |
2021-07-19 7:52 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,253 | $179.14 | 113,698 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 7:52 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,477 | $0 | 113,698 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 7:52 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
550 | $27 | 113,698 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 7:52 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,105 | $46 | 113,698 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 7:52 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
7,952 | $5.95 | 113,698 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 7:52 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
870 | $27.6 | 113,698 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
10,000 | $0 | 76,590 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 5:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
44,999 | $121 | 73,054 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 5:03 pm |
N/A 2022-03-01 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
105,179 | $0 | 73,054 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 5:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
15,181 | $25.6 | 73,054 (Direct) |
View |
2021-07-01 Exercise |
2021-07-06 5:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
44,999 | $36.6 | 73,054 (Direct) |
View |
2021-06-30 Exercise |
2021-07-02 5:01 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,896 | $0 | 66,415 (Direct) |
View |
2021-06-30 Exercise |
2021-07-02 5:01 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
417 | $46 | 66,415 (Direct) |
View |
2021-06-30 Exercise |
2021-07-02 5:01 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,063 | $5.95 | 66,415 (Direct) |
View |
2021-06-30 Exercise |
2021-07-02 5:01 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $27.6 | 66,415 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
6,900 | $0 | 12,851 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | King Rachel K. Director |
6,900 | $0 | 11,900 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:13 pm |
N/A N/A |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
3,450 | $0 | 31,950 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
7,590 | $0 | 66,590 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
834 | $0 | 2,384 (Direct) |
View |
2021-06-25 Tax Withholding |
2021-06-29 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
403 | $189.79 | 2,384 (Direct) |
View |
2021-06-25 Exercise |
2021-06-29 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
834 | $0 | 2,372 (Direct) |
View |
2021-06-25 Tax Withholding |
2021-06-29 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
403 | $189.79 | 2,372 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:20 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:20 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:19 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | MCGLYNN MARGARET G Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:18 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | King Rachel K. Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:16 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:15 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
2,000 | $0 | 2,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-22 5:13 pm |
2022-06-17 2031-06-17 |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
4,000 | $0 | 4,000 (Direct) |
View |
2021-06-17 Exercise |
2021-06-22 5:12 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
3,450 | $0 | 19,549 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 6:17 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,535 | $0 | 121,216 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 6:17 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
623 | $27 | 121,216 (Direct) |
View |
2021-06-15 Tax Withholding |
2021-06-17 6:17 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,254 | $187.07 | 121,216 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 6:17 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,101 | $46 | 121,216 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 6:17 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
7,943 | $5.95 | 121,216 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 6:17 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
868 | $27.6 | 121,216 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:59 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $0 | 68,880 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:59 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
417 | $46 | 68,880 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:59 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,062 | $5.95 | 68,880 (Direct) |
View |
2021-05-28 Exercise |
2021-06-02 4:59 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $27.6 | 68,880 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 5:26 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,531 | $0 | 131,751 (Direct) |
View |
2021-05-17 Tax Withholding |
2021-05-19 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,229 | $140.16 | 131,751 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
619 | $27 | 131,751 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,101 | $46 | 131,751 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
7,943 | $5.95 | 131,751 (Direct) |
View |
2021-05-17 Exercise |
2021-05-19 5:26 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
868 | $27.6 | 131,751 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 5:10 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
3,406 | $0 | 85,585 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 5:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
521 | $46 | 85,585 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 5:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
2,468 | $5.95 | 85,585 (Direct) |
View |
2021-05-05 Tax Withholding |
2021-05-07 5:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
180 | $171.74 | 85,585 (Direct) |
View |
2021-05-05 Exercise |
2021-05-07 5:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO, CBO & Interim CFO |
417 | $27.6 | 85,585 (Direct) |
View |
2021-04-30 Exercise |
2021-05-04 6:03 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $0 | 71,775 (Direct) |
View |
2021-04-30 Exercise |
2021-05-04 6:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $46 | 71,775 (Direct) |
View |
2021-04-30 Exercise |
2021-05-04 6:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,063 | $5.95 | 71,775 (Direct) |
View |
2021-04-30 Exercise |
2021-05-04 6:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $27.6 | 71,775 (Direct) |
View |
2021-04-15 Tax Withholding |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,260 | $202.09 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,531 | $0 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
4,819 | $202.09 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
619 | $27 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,101 | $46 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,124 | $5.95 | 142,282 (Direct) |
View |
2021-04-15 Exercise |
2021-04-19 9:24 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
868 | $27.6 | 142,282 (Direct) |
View |